| Followers | 906 |
| Posts | 39404 |
| Boards Moderated | 15 |
| Alias Born | 03/22/2016 |
Wednesday, August 28, 2024 11:09:10 AM
Recent CMMB News
- Chemomab Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/17/2026 01:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/10/2026 09:43:27 PM
- Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology • GlobeNewswire Inc. • 12/02/2025 01:00:00 PM
- Chemomab to Participate in Oppenheimer’s Movers in Rare Disease Summit • GlobeNewswire Inc. • 11/24/2025 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/21/2025 11:15:37 AM
- Chemomab Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/20/2025 01:00:00 PM
- Chemomab Announces Multiple Presentations at AASLD The Liver Meeting® 2025 Featuring Clinical Data from the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis • GlobeNewswire Inc. • 11/06/2025 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/22/2025 08:05:14 PM
- Chemomab Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference • GlobeNewswire Inc. • 08/21/2025 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/14/2025 12:01:04 PM
- Chemomab Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/14/2025 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/25/2025 08:33:11 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/25/2025 08:05:19 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/01/2025 08:05:42 PM
- Chemomab Announces Oral Presentation of Positive Nebokitug Phase 2 Clinical Data in Primary Sclerosing Cholangitis at BSG Live’25 • GlobeNewswire Inc. • 06/30/2025 12:00:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 06/23/2025 09:06:15 PM
- Chemomab Reports Positive Feedback From Two Recent FDA Meetings Supporting Phase 3 Advancement of Nebokitug in Primary Sclerosing Cholangitis • GlobeNewswire Inc. • 06/11/2025 12:00:00 PM
- Chemomab Announces New Patent Awards for Its First-in-Class Agent Nebokitug that is Positioned to Potentially Become the First Approved Drug for Primary Sclerosing Cholangitis • GlobeNewswire Inc. • 06/03/2025 12:00:00 PM
- Chemomab Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/15/2025 12:00:00 PM
- Chemomab Announces Presentation of Positive Nebokitug Phase 2 Clinical Data in Primary Sclerosing Cholangitis in Distinguished Plenary Session at DDW 2025 • GlobeNewswire Inc. • 05/05/2025 12:00:00 PM
- Chemomab Reports New Positive Clinical Data at EASL 2025 Supporting Nebokitug’s Impact in Primary Sclerosing Cholangitis and Related Diseases • GlobeNewswire Inc. • 04/28/2025 12:00:00 PM
- Chemomab Therapeutics to Present Nebokitug Clinical Data at Upcoming Scientific Conferences • GlobeNewswire Inc. • 04/21/2025 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/15/2025 12:00:43 PM
- Chemomab Announces New Medical and Clinical Appointments • GlobeNewswire Inc. • 04/15/2025 12:00:00 PM
Closing the Intent-to-Execution Gap May Define Next Wave of AI Investment • WLDS • Feb 17, 2026 9:00 AM
Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A • ARWR • Feb 17, 2026 9:00 AM
UPDATE: Hydromer, Inc. Announces Expansion Into High-Speed Automated Coating and UV Cure Equipment Manufacturing • HYDI • Feb 10, 2026 10:58 AM
MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System • MWAI • Feb 10, 2026 8:45 AM
LaFleur Minerals Reports Assay Results Highlighting 2.05 g/t Au over 158.25 metres, Confirming Strong Gold Continuity at Swanson Gold Project • LFLRF • Feb 5, 2026 5:29 AM
DRCR Begins Rollout of New Business Model • DRCR • Feb 4, 2026 12:42 PM
